SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-062516
Filing Date
2018-12-13
Accepted
2018-12-13 18:33:23
Documents
1
Period of Report
2018-12-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10329
  Complete submission text file 0001209191-18-062516.txt   12432
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Reporting) CIK: 0001055951 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-38756 | Film No.: 181234217

Mailing Address 11099 NORTH TORREY PINES ROAD, SUITE 290 LA JOLLA CA 92037
Business Address 11099 NORTH TORREY PINES ROAD, SUITE 290 LA JOLLA CA 92037 858-750-4715
Synthorx, Inc. (Issuer) CIK: 0001609727 (see all company filings)

IRS No.: 464709185 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022 212-739-6491
OrbiMed Capital GP VII LLC (Reporting) CIK: 0001760648 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38756 | Film No.: 181234218